Great Point Partners, LLC 13D and 13G filings for Outlook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 5:15 pm Unchanged | 2025-06-30 | 13G | Outlook Therapeutics, Inc. OTLK | Great Point Partners, LLC | 2,220,000 4.990% | 0 (Unchanged) | Filing |
| 2025-05-15 4:47 pm Unchanged | 2025-03-31 | 13G | Outlook Therapeutics, Inc. OTLK | Great Point Partners, LLC | 2,220,000 6.370% | 0 (Unchanged) | Filing |
| 2025-02-14 4:38 pm Sale | 2024-12-31 | 13G | Outlook Therapeutics, Inc. OTLK | Great Point Partners, LLC | 2,220,000 8.180% | -261,973 (-10.56%) | Filing |
| 2024-11-14 4:55 pm Purchase | 2024-09-30 | 13G | Outlook Therapeutics, Inc. OTLK | Great Point Partners, LLC | 2,481,973 9.990% | 250,649 (+11.23%) | Filing |
| 2024-04-08 4:10 pm Purchase | 2024-04-01 | 13G | Outlook Therapeutics, Inc. OTLK | Great Point Partners, LLC | 2,231,324 9.990% | 2,231,324 (New Position) | Filing |